Idoxuridine: Clinical Trials

4 trials of Idoxuridine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 withdrawn. 4 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 3, Withdrawn 1
Phase 11Completed 1
Phase 31Completed 1

Follow Idoxuridine: new trials by email Literature Review of Idoxuridine trials Research Report on Idoxuridine

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of an Intra-articular Injection of Botulinum Toxin A Associated With Splinting for Base-of-thumb Osteoarthritis
botulinum toxin A, saline - Base-of-thumb Osteoarthritis
Phase 2 / Phase 3CompletedAssistance Publique - Hôpitaux de Paris602018-11-292025-09-05
Botulinum Toxin Type A Block of the Otic Ganglion in Chronic Cluster Headache: Safety Issues
Botulinum Toxin Type A 25 IU, Botulinum Toxin Type A 12.5 IU - Cluster Headache
Phase 1 / Phase 2CompletedNorwegian University of Science and Technology102017-04-182021-06-23
Feasibility Pilot for the ReBOO-trial
Intragastric botulinum toxin type A - Obesity
Phase 2CompletedSt. Olavs Hospital102017-03-142020-09-22
Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia
recombinant interferon alfa, amifostine trihydrate, bromodeoxyuridine - Leukemia
Phase 2WithdrawnRush University Medical Center1998-04-012021-10-14

Conditions studied

Cluster Headache (1)  ·  Ganglion Cysts (1)  ·  Leukemia (1)  ·  Leukemia, Erythroblastic, Acute (1)  ·  Leukemia, Megakaryoblastic, Acute (1)  ·  Leukemia, Monocytic, Acute (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Leukemia, Myelomonocytic, Acute (1)  ·  Obesity (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Norwegian University of Science and Technology (1)  ·  Rush University Medical Center (1)  ·  St. Olavs Hospital (1)

Countries

Norway (2)  ·  France (1)  ·  United States (1)

Top investigators

Lars Jacob Stovner, prof MD (1)  ·  Philip D. Bonomi, MD (1)

Results publications

PMID 29961037, PMID 32583902, PMID 38294016

NIH funding

2016 (2), P01CA075606 (1)